The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System ... reduce hyper- and hypoglycemia, and increase time in range.

People can purchase blood glucose monitors online or discuss with their healthcare team. Severe hypoglycemia can be life threatening, and in rare cases, may lead to death without treatment.

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting wearable on the market.